share_log

Spyre Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Albers Jeffrey W.

SEC ·  Nov 9 06:00
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more